NCT07529717
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07529717
Title First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer (CRIUS-1)
Acronym CRIUS-1
Recruitment Not yet recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site Orlando Florida 32809 United States Details
Research Site East Brunswick New Jersey 08816 United States Details
Research Site Hackensack New Jersey 07601 United States Details
Research Site Providence Rhode Island 02903 United States Details
Research Site Darlinghurst 2010 Australia Details
Research Site Melbourne 3000 Australia Details
Research Site Seoul 03722 South Korea Details
Research Site Seoul 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field